Michael R. Bristow

Biography

 Dr. Michael R. Bristow, M.D., Ph.D., co-founded ARCA Biopharma, Inc. (formerly known as, ARCA Discovery, Inc.) in September 2004 and has been its Chief Executive Officer and President since July 10, 2009. Mr. Bristow served as the Chief Science & Medical Officer of ARCA biopharma, Inc. from November 6, 2006 to July 10, 2009. He founded Gilead Colorado, Inc. and was its Scientific Advisor since February 2006. Mr. Bristow is the Professor of Medicine at the University of Colorado. He co-founded miRagen Therapeutics, Inc. in 2006. He served as Chief Executive Officer and President of ARCA biopharma, Inc., until November 2006. He served as Chief Science and Medical Officer of Myogen Inc. from October 1996 to February 2006. Mr. Bristow served as the Head of Cardiology at the University of Colorado Health Sciences Center and Co-Director of the University of Colorado Cardiovascular Institute. He served as the Chairman at ARCA biopharma, Inc. from November 6, 2006 to July 10, 2009. He was a Director of Gilead Colorado, Inc. (a/k/a Myogen Inc.) since October 1996. He has been a Member of Scientific Advisory Board of miRagen Therapeutics, Inc. since January 2010. He has been a Director of ARCA biopharma, Inc. since January 2009. He served as a Member of Scientific Advisory Board at Nile Therapeutics, Inc. since October 2010. Mr. Bristow served as a Member of the Scientific Advisory Board of Inverseon Inc. He is the author of over 300 peer-reviewed publications and chapters on heart failure or cardiomyopathy for cardiology textbooks, including Braunwald's "Heart Disease: A Textbook of Cardiovascular Medicine" and Hurst's "The Heart." Mr. Bristow holds an M.D. and Ph.D. from the University of Illinois.

Research Interest

 Cardiology